(Q43938517)

28 November 2017

Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. (English)

1 reference

28 November 2017

0 references

Yun J Kim

1

0 references

Anthony Lang

object named as

Anthony E Lang

7

0 references

author name string

Masanori Ichise

2

1 reference

28 November 2017

James R Ballinger

3

1 reference

28 November 2017

Douglas Vines

4

1 reference

28 November 2017

Sean S Erami

5

1 reference

28 November 2017

Tatsuro Tatschida

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

28 November 2017

1 reference

28 November 2017

17

1 reference

28 November 2017

2

1 reference

28 November 2017

303-312

1 reference

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

28 November 2017

1 reference

Dystonia in progressive supranuclear palsy

21 January 2018

1 reference

Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.

21 January 2018

1 reference

Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study

21 January 2018

1 reference

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

21 January 2018

1 reference

Striatonigral degeneration. A clinicopathological study.

21 January 2018

1 reference

Receptor basis for dopaminergic supersensitivity in Parkinson's disease.

21 January 2018

1 reference

Asymmetrical pre-synaptic and post-synpatic changes in the striatal dopamine projection in dopa naïve parkinsonism. Diagnostic implications of the D2 receptor status.

21 January 2018

1 reference

[11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors.

21 January 2018

1 reference

SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD

21 January 2018

1 reference

Dopaminergic and cholinergic lesions in progressive supranuclear palsy

21 January 2018

1 reference

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.

21 January 2018

1 reference

The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.

21 January 2018

1 reference

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

21 January 2018

1 reference

Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease.

21 January 2018

1 reference

Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography.

21 January 2018

1 reference

Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease.

21 January 2018

1 reference

Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data

21 January 2018

1 reference

Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy

21 January 2018

1 reference

Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism

21 January 2018

1 reference

Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease

21 January 2018

1 reference

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

21 January 2018

1 reference

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

21 January 2018

1 reference

Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT

21 January 2018

1 reference

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

21 January 2018

1 reference

Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects.

21 January 2018

1 reference

Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.

21 January 2018

1 reference

Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography

21 January 2018

1 reference

Multiple system atrophy: a review of 203 pathologically proven cases

21 January 2018

1 reference

Dopa resistance in multiple-system atrophy: loss of postsynaptic D2 receptors.

21 January 2018

1 reference

Subregional loss of putaminal efferents to the basal ganglia output nuclei may cause parkinsonism in striatonigral degeneration.

21 January 2018

1 reference

Brain neurotransmitter abnormalities in neuronal intranuclear inclusion body disorder

21 January 2018

1 reference

The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal

21 January 2018

1 reference

[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.10042

1 reference

28 November 2017

1 reference